Trade Mitsui Chemicals, Inc. - 4183 CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 25.5 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.010999% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | -0.011223% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | JPY | ||||||||
Margin | 5% | ||||||||
Stock exchange | Japan | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Mitsui Chemicals Inc ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Prev. Close* | 4297.7 |
Open* | 4301.7 |
1-Year Change* | 41.48% |
Day's Range* | 4270.7 - 4320.6 |
52 wk Range | 2,867.00-4,327.00 |
Average Volume (10 days) | 965.18K |
Average Volume (3 months) | 19.15M |
Market Cap | 850.98B |
P/E Ratio | 13.65 |
Shares Outstanding | 190.14M |
Revenue | 1,752.12B |
EPS | 310.32 |
Dividend (Yield %) | 3.06821 |
Beta | 1.42 |
Next Earnings Date | Feb 3, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 7, 2023 | 4276.7 | -25.0 | -0.58% | 4301.7 | 4325.7 | 4266.7 |
Dec 6, 2023 | 4297.7 | 35.0 | 0.82% | 4262.7 | 4302.3 | 4251.8 |
Dec 5, 2023 | 4207.9 | -4.4 | -0.10% | 4212.3 | 4250.2 | 4189.9 |
Dec 4, 2023 | 4242.8 | 2.3 | 0.05% | 4240.5 | 4252.9 | 4191.0 |
Dec 1, 2023 | 4228.9 | -83.3 | -1.93% | 4312.2 | 4313.9 | 4195.9 |
Nov 30, 2023 | 4316.7 | 15.7 | 0.37% | 4301.0 | 4336.9 | 4288.7 |
Nov 29, 2023 | 4340.5 | 25.8 | 0.60% | 4314.7 | 4352.5 | 4291.7 |
Nov 28, 2023 | 4308.6 | -0.1 | -0.00% | 4308.7 | 4346.9 | 4284.7 |
Nov 27, 2023 | 4294.9 | -49.7 | -1.14% | 4344.6 | 4409.4 | 4288.8 |
Nov 24, 2023 | 4297.6 | 56.8 | 1.34% | 4240.8 | 4332.5 | 4228.0 |
Nov 22, 2023 | 4222.8 | 48.7 | 1.17% | 4174.1 | 4236.9 | 4174.1 |
Nov 21, 2023 | 4105.1 | 60.5 | 1.50% | 4044.6 | 4126.1 | 4037.3 |
Nov 20, 2023 | 4086.2 | -59.9 | -1.44% | 4146.1 | 4146.1 | 4081.2 |
Nov 17, 2023 | 4156.1 | 120.7 | 2.99% | 4035.4 | 4159.5 | 4017.4 |
Nov 16, 2023 | 4027.3 | -5.1 | -0.13% | 4032.4 | 4057.4 | 3976.5 |
Nov 15, 2023 | 4061.4 | -2.9 | -0.07% | 4064.3 | 4080.7 | 4040.3 |
Nov 14, 2023 | 4027.3 | 8.8 | 0.22% | 4018.5 | 4076.4 | 4018.5 |
Nov 13, 2023 | 4007.4 | -2.0 | -0.05% | 4009.4 | 4021.4 | 3965.5 |
Nov 10, 2023 | 3977.6 | 106.6 | 2.75% | 3871.0 | 3977.7 | 3869.8 |
Nov 9, 2023 | 3900.8 | -14.9 | -0.38% | 3915.7 | 3915.7 | 3736.1 |
Mitsui Chemicals, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
Saturday, February 3, 2024 | ||
Time (UTC) 04:00 | Country JP
| Event Q3 2024 Mitsui Chemicals Inc Earnings Release Q3 2024 Mitsui Chemicals Inc Earnings ReleaseForecast -Previous - |
Thursday, March 28, 2024 | ||
Time (UTC) 12:00 | Country JP
| Event Mitsui Chemicals Inc Mitsui Chemicals IncForecast -Previous - |
- Annual
- Quarterly
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Total revenue | 1879550 | 1612690 | 1211720 | 1349520 | 1482910 |
Revenue | 1879550 | 1612690 | 1211720 | 1349520 | 1482910 |
Cost of Revenue, Total | 1498050 | 1233950 | 917883 | 1051140 | 1166580 |
Gross Profit | 381493 | 378740 | 293842 | 298383 | 316332 |
Total Operating Expense | 1750550 | 1465380 | 1133650 | 1284950 | 1387220 |
Selling/General/Admin. Expenses, Total | 284589 | 239356 | 211980 | 226592 | 187109 |
Research & Development | 35796 | ||||
Unusual Expense (Income) | -11656 | 12124 | 9596 | 6819 | -2267 |
Operating Income | 128998 | 147310 | 78074 | 64569 | 95694 |
Interest Income (Expense), Net Non-Operating | -1068 | -1626 | -2659 | -876 | 13426 |
Gain (Loss) on Sale of Assets | -3605 | ||||
Other, Net | -10652 | -4410 | -1172 | -2869 | -218 |
Net Income Before Taxes | 117278 | 141274 | 74243 | 60824 | 105297 |
Net Income After Taxes | 90138 | 118551 | 64219 | 42619 | 86523 |
Minority Interest | -7202 | -8561 | -6346 | -8649 | -10408 |
Net Income Before Extra. Items | 82936 | 109990 | 57873 | 33970 | 76115 |
Net Income | 82936 | 109990 | 57873 | 33970 | 76115 |
Income Available to Common Excl. Extra. Items | 82936 | 109990 | 57873 | 33970 | 76115 |
Income Available to Common Incl. Extra. Items | 82936 | 109990 | 57873 | 33970 | 76115 |
Diluted Net Income | 82936 | 109990 | 57873 | 33970 | 76115 |
Diluted Weighted Average Shares | 192.35 | 194.517 | 194.202 | 194.649 | 197.394 |
Diluted EPS Excluding Extraordinary Items | 431.173 | 565.453 | 298.004 | 174.52 | 385.599 |
Dividends per Share - Common Stock Primary Issue | 120 | 115 | 100 | 100 | 100 |
Diluted Normalized EPS | 384.598 | 617.757 | 340.745 | 199.067 | 394.467 |
Interest Expense (Income) - Net Operating | -21693 | -25819 | -5989 | -4512 | |
Other Operating Expenses, Total | 1255 | 5769 | 181 | 4915 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 407925 | 450636 | 477834 | 474964 | 476113 |
Revenue | 407925 | 450636 | 477834 | 474964 | 476113 |
Cost of Revenue, Total | 320684 | 372988 | 377617 | 375923 | 371526 |
Gross Profit | 87241 | 77648 | 100217 | 99041 | 104587 |
Total Operating Expense | 394038 | 428656 | 443324 | 445405 | 433164 |
Selling/General/Admin. Expenses, Total | 68541 | 75357 | 70624 | 70100 | 68508 |
Interest Expense (Income) - Net Operating | -3080 | -3246 | -4259 | -5178 | -9010 |
Unusual Expense (Income) | 7738 | -18067 | -483 | 4652 | 2242 |
Other Operating Expenses, Total | 155 | 1624 | -175 | -92 | -102 |
Operating Income | 13887 | 21980 | 34510 | 29559 | 42949 |
Interest Income (Expense), Net Non-Operating | 264 | -4889 | -4977 | 276 | -2130 |
Other, Net | |||||
Net Income Before Taxes | 14151 | 17091 | 29533 | 29835 | 40819 |
Net Income After Taxes | 11458 | 18501 | 23061 | 18625 | 29951 |
Minority Interest | -1867 | -511 | -2468 | -2264 | -1959 |
Net Income Before Extra. Items | 9591 | 17990 | 20593 | 16361 | 27992 |
Net Income | 9591 | 17990 | 20593 | 16361 | 27992 |
Income Available to Common Excl. Extra. Items | 9591 | 17990 | 20593 | 16361 | 27992 |
Income Available to Common Incl. Extra. Items | 9591 | 17990 | 20593 | 16361 | 27992 |
Diluted Net Income | 9591 | 17990 | 20593 | 16361 | 27992 |
Diluted Weighted Average Shares | 190.065 | 190.264 | 192.555 | 193.344 | 193.235 |
Diluted EPS Excluding Extraordinary Items | 50.4617 | 94.5529 | 106.946 | 84.621 | 144.86 |
Dividends per Share - Common Stock Primary Issue | 0 | 60 | 0 | 60 | 0 |
Diluted Normalized EPS | 83.4264 | 32.8305 | 104.987 | 99.6413 | 153.373 |
- Annual
- Quarterly
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Total Current Assets | 1094290 | 1033440 | 787572 | 781834 | 786677 |
Cash and Short Term Investments | 262719 | 224648 | 223163 | 201376 | 111056 |
Cash & Equivalents | 185377 | 179754 | 193585 | 163983 | 111056 |
Total Receivables, Net | 376356 | 386352 | 290938 | 284992 | 365161 |
Accounts Receivable - Trade, Net | 339843 | 357221 | 274902 | 261497 | 309873 |
Total Inventory | 441949 | 369009 | 258814 | 284306 | 301890 |
Other Current Assets, Total | 6988 | 47479 | 9616 | 6765 | 8570 |
Total Assets | 2068200 | 1934960 | 1558120 | 1530520 | 1501070 |
Property/Plant/Equipment, Total - Net | 600887 | 553584 | 501960 | 499650 | 443063 |
Property/Plant/Equipment, Total - Gross | 2030730 | 1985550 | 1836070 | 1799940 | 1637100 |
Accumulated Depreciation, Total | -1429840 | -1431970 | -1334110 | -1300290 | -1194030 |
Goodwill, Net | 19338 | 17981 | 1123 | 1476 | 5061 |
Intangibles, Net | 48137 | 45341 | 19678 | 24759 | 24324 |
Long Term Investments | 229123 | 210460 | 178194 | 173752 | 165199 |
Other Long Term Assets, Total | 76432 | 74154 | 69598 | 49044 | 76750 |
Total Current Liabilities | 695444 | 706569 | 466305 | 485674 | 458758 |
Accounts Payable | 161197 | 173032 | 117750 | 117920 | 163908 |
Accrued Expenses | 175 | ||||
Notes Payable/Short Term Debt | 324120 | 297437 | 162182 | 179829 | 102733 |
Current Port. of LT Debt/Capital Leases | 44343 | 49178 | 54539 | 52964 | 57997 |
Other Current Liabilities, Total | 165784 | 186922 | 131834 | 134961 | 133945 |
Total Liabilities | 1281380 | 1222310 | 950204 | 1001300 | 949159 |
Total Long Term Debt | 369786 | 319471 | 293495 | 313237 | 321288 |
Long Term Debt | 369786 | 319471 | 293495 | 313237 | 321288 |
Deferred Income Tax | 35162 | 28133 | 27834 | 23017 | 11471 |
Minority Interest | 96476 | 94468 | 74236 | 80487 | 79824 |
Other Liabilities, Total | 84508 | 73670 | 88334 | 98880 | 77818 |
Total Equity | 786827 | 712654 | 607921 | 529220 | 551915 |
Common Stock | 125572 | 125414 | 125331 | 125298 | 125205 |
Additional Paid-In Capital | 57778 | 69866 | 74009 | 79320 | 89406 |
Retained Earnings (Accumulated Deficit) | 575125 | 516098 | 424084 | 359794 | 348202 |
Treasury Stock - Common | -32704 | -34932 | -24900 | -39254 | -29869 |
Unrealized Gain (Loss) | 21421 | ||||
Other Equity, Total | 61056 | 36208 | 9397 | 4062 | -2450 |
Total Liabilities & Shareholders’ Equity | 2068200 | 1934960 | 1558120 | 1530520 | 1501070 |
Total Common Shares Outstanding | 190.066 | 193.236 | 195.944 | 191.051 | 195.057 |
Short Term Investments | 77342 | 44894 | 29578 | 37393 | |
Prepaid Expenses | 6274 | 5957 | 5041 | 4395 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total Current Assets | 1082520 | 1078870 | 1094290 | 1132300 | 1131380 |
Cash and Short Term Investments | 244019 | 212227 | 262719 | 234673 | 253049 |
Cash & Equivalents | 202563 | 169048 | 186310 | 193408 | 208260 |
Short Term Investments | 41456 | 43179 | 76409 | 41265 | 44789 |
Total Receivables, Net | 319387 | 318876 | 352181 | 379530 | 370019 |
Accounts Receivable - Trade, Net | 319387 | 318876 | 352181 | 379530 | 370019 |
Total Inventory | 441036 | 449087 | 441949 | 455309 | 451270 |
Other Current Assets, Total | 78081 | 98678 | 37437 | 62787 | 57042 |
Total Assets | 2104350 | 2062840 | 2068200 | 2085710 | 2080210 |
Property/Plant/Equipment, Total - Net | 625412 | 598893 | 600887 | 593483 | 585115 |
Goodwill, Net | 20877 | 19524 | 19338 | 19636 | 18130 |
Intangibles, Net | 53152 | 50098 | 48137 | 46683 | 45589 |
Long Term Investments | 239111 | 231808 | 229123 | 226398 | 237177 |
Other Long Term Assets, Total | 83278 | 83646 | 76432 | 67207 | 62821 |
Total Current Liabilities | 681494 | 675043 | 695444 | 754833 | 744574 |
Accounts Payable | 154355 | 137705 | 164267 | 186395 | 188866 |
Notes Payable/Short Term Debt | 0 | 0 | 324120 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 345355 | 371754 | 44343 | 400938 | 368079 |
Other Current Liabilities, Total | 181784 | 165584 | 162714 | 167500 | 187629 |
Total Liabilities | 1273040 | 1253500 | 1281380 | 1320000 | 1303940 |
Total Long Term Debt | 372342 | 362959 | 369786 | 353735 | 346469 |
Long Term Debt | 372342 | 362959 | 369786 | 353735 | 346469 |
Deferred Income Tax | 41541 | 39260 | 35162 | 30204 | 29416 |
Minority Interest | 98338 | 98278 | 96476 | 97079 | 97205 |
Other Liabilities, Total | 79330 | 77964 | 84508 | 84144 | 86281 |
Total Equity | 831308 | 809333 | 786827 | 765711 | 776267 |
Common Stock | 125738 | 125572 | 125572 | 125572 | 125572 |
Additional Paid-In Capital | 57945 | 57778 | 57778 | 57778 | 70024 |
Retained Earnings (Accumulated Deficit) | 588256 | 577386 | 575125 | 549631 | 537654 |
Treasury Stock - Common | -32723 | -32713 | -32704 | -27679 | -34938 |
Other Equity, Total | 92092 | 81310 | 61056 | 44857 | 61797 |
Total Liabilities & Shareholders’ Equity | 2104350 | 2062840 | 2068200 | 2085710 | 2080210 |
Total Common Shares Outstanding | 190.141 | 190.064 | 190.066 | 191.722 | 193.344 |
Unrealized Gain (Loss) | 15552 | 16158 |
- Annual
- Quarterly
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Net income/Starting Line | 117278 | 141274 | 74243 | 60824 | 105297 |
Cash From Operating Activities | 101241 | 92584 | 174323 | 142232 | 109492 |
Cash From Operating Activities | 92080 | 84222 | 76621 | 76009 | 48853 |
Amortization | 651 | ||||
Non-Cash Items | -15519 | -16634 | 2782 | -2582 | -23624 |
Cash Taxes Paid | 34394 | 17036 | 7764 | 19212 | 17124 |
Cash Interest Paid | 5889 | 3972 | 4705 | 5589 | 5507 |
Changes in Working Capital | -92598 | -116278 | 20677 | 7981 | -21685 |
Cash From Investing Activities | -106340 | -205234 | -77555 | -109112 | -64255 |
Capital Expenditures | -137861 | -116216 | -76581 | -99771 | -55755 |
Other Investing Cash Flow Items, Total | 31521 | -89018 | -974 | -9341 | -8500 |
Cash From Financing Activities | 2542 | 89222 | -68956 | -6365 | -14134 |
Financing Cash Flow Items | -22842 | -14873 | -3466 | -6700 | -6118 |
Total Cash Dividends Paid | -24161 | -20527 | -19349 | -19509 | -18878 |
Issuance (Retirement) of Stock, Net | -10018 | -10031 | -688 | -9369 | -10028 |
Issuance (Retirement) of Debt, Net | 59563 | 134653 | -45453 | 29213 | 20890 |
Foreign Exchange Effects | 7715 | 8593 | 3604 | -1673 | -92 |
Net Change in Cash | 5158 | -14835 | 31416 | 25082 | 31011 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 117278 | 100187 | 70654 | 40819 | 141274 |
Cash From Operating Activities | 101241 | 44084 | 21911 | -10642 | 92584 |
Cash From Operating Activities | 92080 | 68800 | 44945 | 21842 | 84222 |
Non-Cash Items | -15519 | -12867 | -9532 | -7036 | -16634 |
Cash Taxes Paid | 34394 | 34478 | 21686 | 14051 | 17036 |
Cash Interest Paid | 5889 | 4157 | 2395 | 1121 | 3972 |
Changes in Working Capital | -92598 | -112036 | -84156 | -66267 | -116278 |
Cash From Investing Activities | -106340 | -67306 | -14042 | -33248 | -205234 |
Capital Expenditures | -137861 | -100127 | -50628 | -32401 | -116216 |
Other Investing Cash Flow Items, Total | 31521 | 32821 | 36586 | -847 | -89018 |
Cash From Financing Activities | 2542 | 29019 | 5508 | 44419 | 89222 |
Financing Cash Flow Items | -22842 | -19782 | -19304 | -3902 | -14873 |
Total Cash Dividends Paid | -24161 | -24161 | -12560 | -12560 | -20527 |
Issuance (Retirement) of Stock, Net | -10018 | -4993 | -6 | -3 | -10031 |
Issuance (Retirement) of Debt, Net | 59563 | 77955 | 37378 | 60884 | 134653 |
Foreign Exchange Effects | 7715 | 6459 | 13731 | 9187 | 8593 |
Net Change in Cash | 5158 | 12256 | 27108 | 9716 | -14835 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Asset Management One Co., Ltd. | Investment Advisor/Hedge Fund | 6.5891 | 13233700 | 12556646 | 2023-06-30 | LOW |
Nomura Asset Management Co., Ltd. | Investment Advisor | 6.1979 | 12448100 | -2095600 | 2022-05-31 | LOW |
Sumitomo Mitsui Trust Asset Management Co., Ltd. | Investment Advisor | 2.9603 | 5945584 | 5928136 | 2023-05-31 | LOW |
Mitsubishi UFJ Trust and Banking Corporation | Bank and Trust | 2.927 | 5878794 | -1369500 | 2023-01-09 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.4468 | 4914299 | -6000 | 2023-09-30 | LOW |
Nikko Asset Management Co., Ltd. | Investment Advisor/Hedge Fund | 2.3827 | 4785600 | 1417391 | 2023-05-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.8147 | 3644698 | -31400 | 2023-09-30 | LOW |
Mitsui & Co Ltd | Holding Company | 1.7297 | 3474000 | 0 | 2023-03-31 | LOW |
Goldman Sachs Asset Management International | Investment Advisor | 1.6951 | 3404458 | 28601 | 2023-09-30 | MED |
Daiwa Asset Management Co., Ltd. | Investment Advisor | 1.6378 | 3289416 | -33476 | 2023-09-30 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.4262 | 2864524 | 248018 | 2022-12-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 1.4017 | 2815222 | 16300 | 2023-09-30 | LOW |
Mitsui Chemicals, Inc. Customers | Corporation | 1.3314 | 2674000 | 65000 | 2023-03-31 | LOW |
Japan Post Insurance Co., Ltd. | Insurance Company | 1.3155 | 2642000 | 2642000 | 2023-03-31 | LOW |
Sumitomo Mitsui Banking Corp | Bank and Trust | 1.2945 | 2600000 | 0 | 2023-03-31 | LOW |
NORINCHUKIN BANK | Bank and Trust | 1.2677 | 2546000 | 0 | 2023-03-31 | LOW |
Taiju Life Insurance Company Limited | Insurance Company | 1.2567 | 2524000 | 0 | 2023-03-31 | LOW |
RBC Global Asset Management (Asia) Limited | Investment Advisor | 1.0964 | 2202128 | -333 | 2023-09-30 | MED |
Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | Investment Advisor | 0.9466 | 1901100 | -46200 | 2023-01-09 | LOW |
Sumitomo Mitsui Trust Bank, Limited | Bank and Trust | 0.6971 | 1400000 | 0 | 2023-05-31 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Mitsui Chemicals, Inc. Company profile
About Mitsui Chemicals, Inc.
Mitsui Chemicals, Inc. is a chemical manufacturer mainly engaged in the manufacture and sale of mobility, healthcare, food & packaging and basic materials. The Company operates in four business segments. The Mobility segment is engaged in the manufacture and sale of elastomers, functional compounds, functional polymers and polypropylene compounds. The Healthcare segment is engaged in the manufacture and sale of vision care materials, nonwoven fabrics, dental materials and personal care materials. The Food & Packaging segment is engaged in the manufacture and sale of coatings and functional materials, functional films, sheets and pesticides. The Basic Material segment is engaged in the manufacture and sale of petrochemical raw materials such as ethylene and propylene, polyethylene, catalyst, phenol, high purity terephthalic acid, pet resin, polyurethane material and industrial chemicals.
Financial summary
BRIEF: For the nine months ended 31 December 2021, Mitsui Chemicals, Inc. revenues increased 36% to Y1.165T. Net income increased from Y33B to Y100.07B. Revenues reflect Mobility segment increase of 34% to Y296.95B, Food & Packing business segment increase of 19% to Y165.79B. Net income benefited from Equity in Loss of Affiliates increase from Y950M to Y21.98B (income), Other Operating Income increase of 85% to Y2.2B (income).
Equity composition
FY'94-02, FY'04-'06 1&3Q WAS & O/S were estimated. An increase in o/s in FY'98 due to the merger. FY'08 1Q & 3Q WAS was estimated and used for O/S.
Industry: | Commodity Chemicals (NEC) |
東京ミッドタウン八重洲 八重洲セントラルタワー
八重洲2-2-1
CHUO-KU
TOKYO-TO 104-0028
JP
Income Statement
- Annual
- Quarterly
News

December RBA preview: no move expected at the final meeting of 2023
The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.
14:47, 4 December 2023
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
12:39, 30 November 2023
Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com